Immuno-Viva® Researchers Awarded Prestigious Government Grant

We are very proud to announce that the National Institutes of Health just awarded a large federal grant to the laboratory of Immuno-Viva researchers Dr. Arnold Leonard and Dr. Dan Saltzman. The grant has been awarded to their bioengineering lab at the University of Minnesota which is working on a genetically engineered cancer therapy. This research has garnered national attention from within the medical community, and this NIH grant is a prestigious vote of confidence from the government for this pioneering work involving cancer and the immune system. The $411,000 grant will be used in researching the effects of their therapy on pancreatic cancer.

About the Cancer Research

Dr. Leonard and Dr. Saltzman, along with their staff at the Immunology and Biology Lab at the University of Minnesota, are on the cutting edge of cancer research. They have developed a genetically engineered strain of Salmonella which has lost its' ability to cause disease, yet has a unique capacity to infiltrate tumors in a variety of locations including the lung and liver. In addition, a human gene acting as a powerful immune stimulant has been added to the bacteria. Thus, when given orally, the Salmonella will infiltrate tumors and deliver this immune stimulant that enlists the body's own defenses to destroy the tumor. To date, Drs. Saltzman and Leonard have studied colon cancer, neuroblastoma, and osteogenicsarcoma. In the lab, the cancer biotherapy has produced significant results in tumor reduction without the complications associated with traditional chemotherapy.

The Future of Fighting Cancer

The Food and Drug Administration is reviewing an investigational new drug application for the biotherapy. Upon approval, the doctors will be able to proceed with human clinical trials. This is a big first step towards gaining federal approval as a cancer drug. If the human study results are in line with the lab work, the medical community may have an incredible new tool for fighting cancer.

Immuno-Viva’s Role

By adding a strong daily dose of Immuno-Viva Core, the researchers found that the immune system strengthened significantly, working synergistically with the cancer therapy and increasing its effectiveness. This breakthrough in the lab has lead to extensive research into Immuno-Viva Core, and its effects on the immune system, inflammatory function and cardiovascular health. Drs. Saltzman and Leonard have helped develop and test the entire Immuno-Viva line of products, and are driving research on the impact the products have on numerous modern health conditions.* We are honored to have such highly respected scientists leading our Immuno-Viva research!

Newsletter Exclusive: Immuno-Viva® Free Trial Offer

We have an exciting opportunity just for our Newsletter members this month. From now until the end of April, you can try any new Immuno-Viva product for FREE.

Offer Details: Sign up for our refill program and you’ll get your first bottle of any Immuno-Viva product FREE — you just pay shipping. This is a great opportunity for you to try a new product, and if you like it, you’ll receive monthly refills at 10% off the standard retail price. Talk about a win-win situation!

Ready to give it a try? It’s as easy as 1-2-3.

1. Pick out a product and add it to the shopping cart
2. Click the “Refill” button, then proceed to checkout
3. Fill out the order form, and enter Promo Code FT042008

Or you can call 715-635-7513 to place your order over the phone.

Offer valid for retail customers only on individual, in stock products, limit 1 free bottle per customer. If you select multiple products, the Free Trial will apply only to the highest priced product. If you’re not completely satisfied, you can cancel the refill program at any time.

We hope you take advantage of this unique opportunity to test out a product you have yet to try; we know you’ll be happy with the results!

Sincerely,

— Mark Mueller, President, Botanic Oil Innovations